Benalaxyl

Benalaxyl

SCHEMBL6406729

COC(=O)C(C)N(C(=O)Cc1ccccc1)c1c(C)cccc1C.COCC(=O)N(c1c(C)cccc1C)C(C)C(=O)OC

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.55
MEN1 O00255 6/20 0.55
PLA2G1B P04054 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ATG4B Q9Y4P1 1/20 0.55
TRPM8 Q7Z2W7 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
RORC P51449 1/20 0.38
HPGD P15428 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TSHR P16473 1/20 0.37
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benalaxyl SCHEMBL8818251 0.94 KMT2A (0.61) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL41642 0.94 KMT2A (0.61) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL54808 0.94 KMT2A (0.61) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL21674 0.94 KMT2A (0.61) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL2528870 0.94 KMT2A (0.61) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL27822944 0.93 KMT2A (0.60) KMT2AMEN1PLA2G1BHTTNPSR1
Benalaxyl SCHEMBL7182610 0.93 KMT2A (0.60) KMT2AMEN1PLA2G1BHTTNPSR1
Metalaxyl SCHEMBL20990 0.90 KMT2A (0.58) KMT2AMEN1PLA2G1BHTTNPSR1
Mefenoxam SCHEMBL22529 0.90 KMT2A (0.58) KMT2AMEN1PLA2G1BHTTNPSR1
Metalaxyl SCHEMBL5070290 0.90 KMT2A (0.58) KMT2AMEN1PLA2G1BHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050164999-A1 Benzamides and compositions benzamides for use as fungicizide E. I. DU PONT DE NEMOURS AND COMPANY 2005-07-28 US disclosed
US-20050020644-A1 Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides E.I. DU PONT DE NEMOURS AND COMPANY 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020644-A1 Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides CBR3, CBR1, PNPO KMT2A 3925/4885MEN1 1190/4885PLA2G1B 4000/4885
US-20050164999-A1 Benzamides and compositions benzamides for use as fungicizide CYC1, ME3, ME2 KMT2A 1890/4885MEN1 2554/4885PLA2G1B 992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.